IPOs

SK Biopharmaceuticals IPO Tabbed to Raise $850 Million
SK Biopharmaceuticals IPO Tabbed to Raise $850 Million
Yahoo/Guru Focus
SK Biopharmaceuticals
IPOs
South Korea
epilepsy
Xcopri
Flag link:
A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole
A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole
Yahoo/Benzinga
Aquestive Therapeutics
FDA
IPOs
PharmFilm
riluzole
Flag link:
SK Biopharmaceuticals, fresh off an FDA nod, preps for $850M IPO in January: report
SK Biopharmaceuticals, fresh off an FDA nod, preps for $850M IPO in January: report
Fierce Pharma
SK Biopharmaceuticals
South Korea
FDA
Xcopri
IPOs
Flag link:
Teva spinout delays NASH IPO while Galera prices below range
Teva spinout delays NASH IPO while Galera prices below range
Endpoints
Teva Pharmaceutical
89Bio
Galera
IPOs
Flag link:
A tale of two IPOs (plus one): Cabaletta prices well below range for $75M while Phathom bags $182M
A tale of two IPOs (plus one): Cabaletta prices well below range for $75M while Phathom bags $182M
Endpoints
IPOs
Cabaletta Bio
Phathom Pharmaceuticals
Flag link:
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
Yahoo/Benzinga
earnings
Eli Lilly
Alexion
Gilead Sciences
Biomarin
Edwards Lifesciences
Baxter International
Integra LifeSciences
Phathom Pharmaceuticals
IPOs
Foamix
Eton Pharmaceuticals
Melinta Therapeutics
Ligand Pharmaceuticals
Flag link:
TELA Bio Files for $69 Million IPO
TELA Bio Files for $69 Million IPO
CP Wire
TELA Bio
IPOs
Ovitex
devices
Flag link:
TELA Bio Files for $69 Million IPO
TELA Bio
IPOs
Ovitex
devices
Flag link:
Eyeing $86M, Galera leads a pack of three modest biotech IPOs pushing past high profile stumbles
Eyeing $86M, Galera leads a pack of three modest biotech IPOs pushing past high profile stumbles
Endpoints
IPOs
Galera Therapeutics
89Bio
Centogene
Flag link:
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Will The Pace of M&A Pick Up Following The Biotech Sector’s Pounding?
Motley Fool
biotech
IPOs
M&A
Flag link:
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Xconomy
Vir Biotechnology
IPOs
infectious diseases
Flag link:
Wall Street trims cancer drug developer BioNTech's unicorn valuation
Wall Street trims cancer drug developer BioNTech's unicorn valuation
Endpoints
NASDAQ
IPOs
BioNTech
Flag link:
Oyster Point Pharma Files for $85 Million IPO
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Flag link:
Oyster Point Pharma Files for $85 Million IPO
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Flag link:
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Flag link:
Cabaletta Bio Files for $100 Million IPO
Cabaletta Bio Files for $100 Million IPO
CP Wire
Cabaletta Bio
IPOs
autoimmune disease
DSG3-CAART
pemphigus vulgaris
Flag link:
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
Gene Therapy Focused 4D Molecular Therapeutics Files for $100 Million IPO
CP Wire
4D Molecular Therapeutics
IPOs
gene therapy
Flag link:
Gene-Editing Company Beam Seeks $100 Million IPO
Gene-Editing Company Beam Seeks $100 Million IPO
BioSpace
Beam Therapeutics
IPOs
gene editing
Flag link:
Led by BioNTech, six biotechs line up for October IPOs
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Flag link:
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
Beam Therapeutics Preps IPO and Sheds Light on Its Gene-Editing Drugs
Xconomy
Beam Therapeutics
IPOs
CRISPR
Flag link:

Pages